PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
3.370
0.00 (0.00%)
Jan 8, 2026, 12:44 PM EST - Market open

Company Description

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.

The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.

It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards.

The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express, Inc.
PetMed Express logo
CountryUnited States
Founded1996
IndustryPharmaceutical Retailers
SectorHealthcare
Employees173
CEOLeslie C. Campbell

Contact Details

Address:
420 South Congress Avenue
Delray Beach, Florida 33445
United States
Phone561 526 4444
Website1800petmeds.com

Stock Details

Ticker SymbolPETS
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearApril - March
Reporting CurrencyUSD
CIK Code0001040130
CUSIP Number716382106
ISIN NumberUS7163821066
Employer ID65-0680967
SIC Code5912

Key Executives

NamePosition
Leslie C. G. CampbellExecutive Chairman of the Board, Interim Chief Executive Officer and President
Douglas KrulikChief Accounting Officer, Principal Acc. Off., Interim Principal Financial Officer and Treasurer
Caroline ConeglianoChief Operating Officer
Robert LawskyCorporate Secretary and General Counsel
Jacqueline SmithVice President of People
Umesh SripadChief Digital and Technology Officer
Wendy ZalaiCorporate Controller and Corporate Secretary

Latest SEC Filings

DateTypeTitle
Dec 29, 20258-K/A[Amend] Current report
Dec 19, 202510-QQuarterly Report
Dec 19, 202510-QQuarterly Report
Dec 11, 2025SCHEDULE 13D/AFiling
Dec 10, 2025DEF 14AOther definitive proxy statements
Dec 9, 20258-KCurrent Report
Nov 26, 20258-A12B/AFiling
Nov 26, 20258-KCurrent Report
Nov 13, 20258-KCurrent Report
Nov 12, 2025NT 10-QNotification of inability to timely file Form 10-Q or 10-QSB